Allianz Asset Management
PTX

Allianz Asset Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Allianz Asset Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-51,880
Closed -$3.07M – 2497
2015
Q2 		$3.07M Sell
51,880
-58,819
-53% -$4.15M ﹤0.01% 1543
2015
Q1 		$11.8M Buy
110,699
+56,115
+103% +$5.35M 0.01% 878
2014
Q4 		$5.13M Sell
54,584
-606
-1% -$57.8K 0.01% 1206
2014
Q3 		$4.24M Sell
55,190
-1,085
-2% -$85.4K 0.01% 1146
2014
Q2 		$5.05M Buy
+56,275
New +$3.45M 0.01% 932

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Allianz Asset Management's PTX Position: Q3 2015 in Review

Allianz Asset Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2015, closing a stake of 51,880 shares — an estimated $3.07M sold.

Allianz Asset Management first reported a position in PTX in Q2 2014 and held it in 5 quarters. The position peaked at $11.8M in Q1 2015. 104 funds tracked by Wall St. Rank hold PTX as of Q3 2015.

  • Allianz Asset Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
  • Allianz Asset Management sold 51,880 Pernix Therapeutics Holdings, Inc. shares in Q3 2015, an estimated $3.07M.
  • Allianz Asset Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 5 quarters.
  • Allianz Asset Management's Pernix Therapeutics Holdings, Inc. position peaked at $11.8M in Q1 2015.
  • 104 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2015.

Based on Allianz Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.